Product Name |
Nirmatrelvir Amide |
Alternate Names |
Nirmatrelvir Impurities, Impurities of Nirmatrelvir |
CAT No. |
CS-O-40554
|
CAS No. |
2755812-81-6 |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
517.54 g/mol |
Mol. For. |
C₂₃H₃₄F₃N₅O₅
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Nirmatrelvir |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Nirmatrelvir Amide is a potent inhibitor of the SARS-CoV-2 main protease, which plays a vital role in the replication of the virus. This protease cleaves the viral polyprotein into functional proteins required for viral replication, making it an attractive target for antiviral drug development. Nirmatrelvir Amide is a small molecule drug that binds to the active site of the protease, preventing its function and ultimately inhibiting viral replication.
Nirmatrelvir Amide has shown promise in clinical trials as a treatment for COVID-19, demonstrating a significant reduction in viral load and an improvement in clinical outcomes. It is typically administered orally and has a half-life of approximately 8 hours.
From a chemical perspective, Nirmatrelvir Amide is a prodrug that is rapidly metabolized in the liver to its active form, Nirmatrelvir. It is a relatively small molecule with a molecular weight of 563.6 g/mol and a melting point of 150-152°C. It is a white to off-white crystalline powder that is soluble in water and organic solvents.
Overall, Nirmatrelvir Amide is a promising antiviral drug that has demonstrated efficacy against SARS-CoV-2 in clinical trials. Its mechanism of action and chemical properties make it a valuable addition to the fight against COVID-19.